Business Context and Reporting Period
Company: SeaStar Medical Holding Corporation (ICU)
Filing Type: Form 8-K (Current Report)
Date of Report: March 11, 2025
Event: Receipt of a decision letter from the Nasdaq Hearings Panel regarding the Company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding listing standards.
Material Changes and Regulatory Status
The Company received an exception from the Nasdaq Hearings Panel to continue its listing on The Nasdaq Stock Market. This decision addresses a deficiency in compliance with Nasdaq Listing Rule 5550(b)(2) (Market Value of Listed Securities or MVLS Rule), which requires a market value of at least $35 million.
- Compliance Deadline: June 22, 2025.
- Compliance Plan: Continuation of fundraising efforts initiated in 2024 and strategies for long-term MVLS compliance.
Conditions, Outlook, and Management Commentary
To maintain listing status, the Company must meet the following conditions by June 22, 2025:
- File a public disclosure describing transactions undertaken to increase equity and provide an indication of equity levels following those transactions.
- Provide the Panel with an update on fundraising plans and updated income projections for the next 12 months, including clearly stated underlying assumptions.
Management states it is taking steps to address these conditions and remains confident in its ability to meet all applicable requirements within the specified timeframes.
Investor Verification Checklist
- Verify the Company's current market capitalization and whether it meets the $35 million MVLS threshold.
- Monitor upcoming public disclosures for details on equity-raising transactions.
- Review the updated income projections and fundraising plans to be submitted to Nasdaq by June 22, 2025.
- Assess the progress of fundraising efforts that began in 2024.